Publication:
Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis

dc.contributor.authorCoca Prieto, Inmaculada
dc.contributor.authorValdivielso Felices, Pedro
dc.contributor.authorOlivecrona, Gunilla
dc.contributor.authorAriza, María José
dc.contributor.authorRioja, José
dc.contributor.authorFont-Ugalde, Pilar
dc.contributor.authorGarcía Arias, Carlota
dc.contributor.authorGonzález Santos, Pedro
dc.contributor.authoraffiliation[Coca-Prieto,I; Valdivielso,P; García-Arias, C; González-Santos,P] Unidad de Lípidos, Servicio de Medicina Interna, Hospital Universitario Virgen de la Victoria, Málaga [Coca-Prieto,I; Valdivielso,P; García-Arias, C; González-Santos,P] Departamento de Medicina, Universidad de Málaga, Málaga, Spain. [Olivecrona,G] Department of Medical Biosciences, Umeå University, Umeå, Sweden. [Ariza,MJ; Rioja,J] Laboratorio de Lípidos y Arteriosclerosis, Centro de Investigaciones Médico-Sanitarias, Universidad de Málaga, Malaga, Spain. [Font-Ugalde,P] Departamento de Medicina, Facultad de Medicina, Universidad de Córdoba, Córdoba, Spain.es
dc.contributor.funderPart of the studies were financed by grants from the Swedish Research Council and from the King Gustaf V and Queen Victoria Research Fund and by grants from Grupos de Investigacion y Desarrollo Tecnologico de la Junta de Andalucia (Grupo consolidado CTS- 159).
dc.date.accessioned2013-03-12T12:57:58Z
dc.date.available2013-03-12T12:57:58Z
dc.date.issued2009-06-17
dc.descriptionJournal Article; Research Support, Non-U.S. Gov't;es
dc.description.abstractBACKGROUND Severe hypertriglyceridaemia due to chylomicronemia may trigger an acute pancreatitis. However, the basic underlying mechanism is usually not well understood. We decided to analyze some proteins involved in the catabolism of triglyceride-rich lipoproteins in patients with severe hypertriglyceridaemia. METHODS Twenty-four survivors of acute hypertriglyceridaemic pancreatitis (cases) and 31 patients with severe hypertriglyceridaemia (controls) were included. Clinical and anthropometrical data, chylomicronaemia, lipoprotein profile, postheparin lipoprotein lipase mass and activity, hepatic lipase activity, apolipoprotein C II and CIII mass, apo E and A5 polymorphisms were assessed. RESULTS Only five cases were found to have LPL mass and activity deficiency, all of them thin and having the first episode in childhood. No cases had apolipoprotein CII deficiency. No significant differences were found between the non-deficient LPL cases and the controls in terms of obesity, diabetes, alcohol consumption, drug therapy, gender distribution, evidence of fasting chylomicronaemia, lipid levels, LPL activity and mass, hepatic lipase activity, CII and CIII mass or apo E polymorphisms. However, the SNP S19W of apo A5 tended to be more prevalent in cases than controls (40% vs. 23%, NS). CONCLUSION Primary defects in LPL and C-II are rare in survivors of acute hypertriglyceridaemic pancreatitis; lipase activity measurements should be restricted to those having their first episode during childhood.es
dc.description.versionYeses
dc.identifier.citationCoca-Prieto I, Valdivielso P, Olivecrona G, Ariza MJ, Rioja J, Font-Ugalde P, et al. Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis. BMC Gastroenterol; 9:46es
dc.identifier.doi10.1186/1471-230X-9-46
dc.identifier.essn1471-230X
dc.identifier.pmcPMC2705373
dc.identifier.pmid19534808
dc.identifier.urihttp://hdl.handle.net/10668/825
dc.journal.titleBMC Gastroenterology
dc.language.isoen
dc.publisherBIOMED CENTRAL LTDes
dc.relation.publisherversionhttp://www.biomedcentral.com/1471-230X/9/46es
dc.rights.accessRightsopen access
dc.subjectApolipoproteína C-IIes
dc.subjectApolipoproteínas Aes
dc.subjectApolipoproteínas Ees
dc.subjectTriglicéridoses
dc.subjectLipoproteína Lipasaes
dc.subjectAdultoes
dc.subjectEstudios de Casos y Controleses
dc.subjectFemeninoes
dc.subjectPredisposición Genética a la Enfermedades
dc.subjectHumanoses
dc.subjectHipertrigliceridemiaes
dc.subjectHígadoes
dc.subjectMasculinoes
dc.subjectMediana Edades
dc.subjectPancreatitises
dc.subjectFactores de Riesgoes
dc.subjectEnfermedad Agudaes
dc.subject.meshMedical Subject Headings::Named Groups::Persons::Age Groups::Adultes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Lipoproteins::Apolipoproteins::Apolipoproteins C::Apolipoprotein C-IIes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Lipoproteins::Apolipoproteins::Apolipoproteins Aes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Lipoproteins::Apolipoproteins::Apolipoproteins Ees
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studieses
dc.subject.meshMedical Subject Headings::Check Tags::Femalees
dc.subject.meshMedical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Susceptibility::Genetic Predisposition to Diseasees
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses
dc.subject.meshMedical Subject Headings::Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Lipid Metabolism Disorders::Dyslipidemias::Hyperlipidemias::Hypertriglyceridemiaes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Esterases::Carboxylic Ester Hydrolases::Lipoprotein Lipasees
dc.subject.meshMedical Subject Headings::Anatomy::Digestive System::Liveres
dc.subject.meshMedical Subject Headings::Check Tags::Malees
dc.subject.meshMedical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Agedes
dc.subject.meshMedical Subject Headings::Diseases::Digestive System Diseases::Pancreatic Diseases::Pancreatitises
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Variation::Polymorphism, Genetices
dc.subject.meshMedical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Epidemiologic Factors::Causality::Risk Factorses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Glycerides::Triglycerideses
dc.subject.meshMedical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Acute Diseasees
dc.titleLipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitises
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Coca_Lipoprotein.pdf
Size:
458.17 KB
Format:
Adobe Portable Document Format
Description:
Artículo publicado